Eli Lilly Stock: Buy The GLP-1 Growth Premium (NYSE:LLY)
· seekingalpha.com
Eli Lilly tirzepatide-based products, Mounjaro and Zepbound, drive nearly $15 billion in revenue. Read why LLY stock is a buy.
Eli Lilly ( LLY ) announced plans for a $3 billion facility in Katwijk, The Netherlands, in November last year. The municipal council of Katwijk has now approve...